The evolution in the prioritization for liver transplantation

Policies for organ allocation can be based on medical urgency, utility or transplant benefit. With an urgency policy, patients with worse outcomes on the waiting list are given higher priority for transplantation [based on the Child–Turcotte–Pugh score or the Model for End-stage Liver Disease (MELD) score, or United Kingdom model for End-stage Liver Disease (UKELD) score]. The MELD and UKELD scores have statistical validation and use objective and widely available laboratory tests. However, both scores have important limitations. Adjustments to the original MELD equation and new scoring systems have been proposed to overcome these limitations; incorporation of serum sodium improves its predictive accuracy and is part of the UKELD score. The utility-based systems are based on post-transplant outcome taking into account donor and recipient characteristics. MELD and UKELD scores poorly predict outcomes after liver transplantation due to the absence of donor factors. The transplant benefit models rank patients according to the net survival benefit that they would derive from transplantation. These models would be based on the maximization of the lifetime gained through liver transplantation. Well-designed prospective studies and simulation models are necessary to establish the optimal allocation system in liver transplantation, as no current model has all the best characteristics.

[1]  J. Trotter,et al.  The International Normalized Ratio (INR) in the MELD Score: Problems and Solutions , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  N. Madias,et al.  Serum creatinine and renal function. , 1988, Annual review of medicine.

[3]  D. Valla,et al.  Assessment of Prognosis of Cirrhosis , 2008, Seminars in liver disease.

[4]  J. Neuberger The introduction of MELD‐based organ allocation impacts 3‐month survival after liver transplantation by influencing pretransplant patient characteristics , 2009, Transplant international : official journal of the European Society for Organ Transplantation.

[5]  S. Sherlock,et al.  Portal-systemic encephalopathy; neurological complications of liver disease. , 1954, Lancet.

[6]  I. Colle,et al.  Impact of MELD on short-term and long-term outcome following liver transplantation: a European perspective , 2005, European journal of gastroenterology & hepatology.

[7]  E. Cholongitas,et al.  Systematic review: the model for end‐stage liver disease – should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis? , 2005, Alimentary pharmacology & therapeutics.

[8]  J. Tuttle-Newhall,et al.  Disparities in liver transplantation before and after introduction of the MELD score. , 2008, JAMA.

[9]  W. Chapman,et al.  Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function1 , 2004, Transplantation.

[10]  T. Therneau,et al.  A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. , 2011, Gastroenterology.

[11]  C. Sabin,et al.  Towards a better liver transplant allocation system , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  J. Kalbfleisch,et al.  Survival Benefit‐Based Deceased‐Donor Liver Allocation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  R. Wolfe,et al.  Longitudinal assessment of mortality risk among candidates for liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  D. E. Schaubela,et al.  The Survival Benefit of Deceased Donor Liver Transplantation as a Function of Candidate Disease Severity and Donor Quality , 2008 .

[15]  D. Valla,et al.  Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. , 2005, Journal of hepatology.

[16]  Mohamed Rela,et al.  Pretransplant MELD score and post liver transplantation survival in the UK and Ireland , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  June-Sung Lee,et al.  [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month]. , 2007, The Korean journal of hepatology.

[18]  M. Lucey How will patients be selected for transplantation in the future? , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  Laura Marelli,et al.  Different methods of creatinine measurement significantly affect MELD scores , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[20]  T. Gonwa,et al.  Continued Influence of Preoperative Renal Function on Outcome of Orthotopic Liver Transplant (OLTX) in the US: Where Will MELD Lead Us? , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  R. Adam,et al.  Liver transplantation: the current situation. , 2009, Seminars in liver disease.

[22]  C. Pilette,et al.  Comparison and Improvement of MELD and Child-Pugh Score Accuracies for the Prediction of 6-month Mortality in Cirrhotic Patients , 2009, Journal of clinical gastroenterology.

[23]  F L Grover,et al.  Development of the New Lung Allocation System in the United States , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  E. Messou,et al.  Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients. , 2008, World journal of gastroenterology.

[25]  R. Wiesner,et al.  Results of the first year of the new liver allocation plan , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[26]  P. Kamath,et al.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.

[27]  A. Gimson,et al.  Development of a UK score for patients with end-stage liver disease , 2007 .

[28]  T. Therneau,et al.  Hyponatremia and mortality among patients on the liver-transplant waiting list. , 2008, The New England journal of medicine.

[29]  E. Vittinghoff,et al.  Ascites improves upon plus serum sodium model for end‐stage liver disease (MELD) for predicting mortality in patients with advanced liver disease , 2009, Alimentary pharmacology & therapeutics.

[30]  E. Cholongitas,et al.  Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[31]  A. Burroughs,et al.  Towards a better liver allocation system. , 2009, Journal of hepatology.

[32]  F. Villamil,et al.  Who should get a liver graft? , 2009, Journal of hepatology.

[33]  Samantha C Huo,et al.  Comparison of four model for end‐stage liver disease–based prognostic systems for cirrhosis , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[34]  E. Cholongitas,et al.  Female Liver Transplant Recipients with the Same GFR as Male Recipients Have Lower MELD Scores—A Systematic Bias , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[35]  S. Sherlock,et al.  Control of ascites in hepatic cirrhosis. , 1954, Lancet.

[36]  J. Bosch,et al.  An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[37]  J. Perkins,et al.  D‐MELD, a Simple Predictor of Post Liver Transplant Mortality for Optimization of Donor/Recipient Matching , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[38]  M. Masetti,et al.  Survival Benefit After Liver Transplantation: A Single European Center Experience , 2009, Transplantation.

[39]  R. Wiesner,et al.  Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.

[40]  R. Wiesner Patient selection in an era of donor liver shortage: current US policy , 2005, Nature Clinical Practice Gastroenterology &Hepatology.

[41]  J J Fung,et al.  Liver Transplantation in the United States, 1999–2008 , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[42]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[43]  A. Burroughs,et al.  Selection of patients for liver transplantation and allocation of donated livers in the UK , 2007, Gut.

[44]  Samantha C Huo,et al.  Is the Corrected-Creatinine Model for End-Stage Liver Disease a Feasible Strategy to Adjust Gender Difference in Organ Allocation for Liver Transplantation? , 2007, Transplantation.

[45]  M. Bartels,et al.  Overview of the MELD score and the UNOS adult liver allocation system. , 2007, Transplantation proceedings.

[46]  C. Sima,et al.  Re-weighting the model for end-stage liver disease score components. , 2008, Gastroenterology.

[47]  M. Biselli,et al.  Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner? , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[48]  J. Bragg-Gresham,et al.  Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[49]  N D Heaton,et al.  Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease , 2006, Gut.

[50]  M. Navasa,et al.  Clinically relevant differences in the model for end‐stage liver disease and model for end‐stage liver disease–sodium scores determined at three university‐based laboratories of the same area , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[51]  T M Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001, Hepatology.

[52]  N. Madias,et al.  Serum creatinine as an index of renal function: new insights into old concepts. , 1992, Clinical chemistry.

[53]  D. Shawcross,et al.  Meld score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation , 2007 .

[54]  A. Tripodi,et al.  The international normalized ratio calibrated for cirrhosis (INRliver) normalizes prothrombin time results for model for end‐stage liver disease calculation , 2007, Hepatology.

[55]  F. Chang,et al.  Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. , 2005, Journal of hepatology.

[56]  R. Fisher,et al.  MELD‐XI: A rational approach to “sickest first” liver transplantation in cirrhotic patients requiring anticoagulant therapy , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[57]  W. Kim,et al.  Is the change in MELD score a better indicator of mortality than baseline MELD score? , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[58]  G. Auzinger,et al.  Increased model for end‐stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[59]  A. Gimson,et al.  Elective Liver Transplant List Mortality: Development of a United Kingdom End-Stage Liver Disease Score , 2011, Transplantation.

[60]  P. Terasaki,et al.  Liver transplantation in the United States. , 2005, Clinical transplants.

[61]  C. Sabin,et al.  3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome , 2006, The Lancet.

[62]  R. Freeman Mathematical Models and Behavior: Assessing Delta MELD for Liver Allocation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[63]  J. Neuberger Allocation of donor livers — is MELD enough? , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[64]  A. Burroughs,et al.  Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. , 2010, Gastroenterology.

[65]  T. Therneau,et al.  Predicting Survival among Patients Listed for Liver Transplantation: An Assessment of Serial MELD Measurements , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[66]  W. Kim,et al.  Organ allocation for chronic liver disease: model for end-stage liver disease and beyond , 2010, Current opinion in gastroenterology.

[67]  J. Trotter,et al.  Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[68]  A. Burroughs,et al.  Assessment of reproducibility of creatinine measurement and MELD scoring in four liver transplant units in the UK. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[69]  Giacomo Germani,et al.  Prioritization for liver transplantation , 2010, Nature Reviews Gastroenterology &Hepatology.

[70]  Laura Marelli,et al.  A systematic review of the performance of the model for end‐stage liver disease (MELD) in the setting of liver transplantation , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[71]  Y. Cho,et al.  Model for end‐stage liver disease, model for end‐stage liver disease‐sodium and Child–Turcotte–Pugh scores over time for the prediction of complications of liver cirrhosis , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[72]  V. Arroyo,et al.  MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation , 2007, Gut.

[73]  E. Christensen Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go? , 2004, Journal of hepatology.

[74]  R. Wolfe,et al.  The Survival Benefit of Liver Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[75]  E. Cholongitas,et al.  Review article: renal function assessment in cirrhosis – difficulties and alternative measurements , 2007, Alimentary pharmacology & therapeutics.

[76]  G. Ioannou,et al.  Development and validation of a model predicting graft survival after liver transplantation , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.